Form 4: Ormat CEO Sells Shares After SAR Exercise
Insider Transaction Report
Ormat Technologies CEO Doron Blachar exercised Stock Appreciation Rights and sold common stock under a pre-arranged 10b5-1 plan.
Summary
- CEO Doron Blachar exercised 45,365 Stock Appreciation Rights (SARs) on September 29, 2025, with an exercise price of $63.40.
- Following the SAR exercise, 14,994 shares of common stock were issued.
- Concurrently, 14,994 shares of common stock were sold in the open market at a weighted average price of $94.71 per share, pursuant to a Rule 10b5-1 plan adopted on June 30, 2025.
- The sale price ranged from $94.33 to $94.89 per share.
- After these transactions, Blachar directly owns 35,419 shares of common stock and 0 SARs.
Sentiment
Score: 6
Explanation: The CEO exercised Stock Appreciation Rights and sold shares under a pre-arranged 10b5-1 plan, which is a routine compensation-related transaction. The sale price was significantly above the SAR exercise price, indicating a profitable realization for the CEO.
Positives
- The CEO exercised Stock Appreciation Rights, indicating a realization of value from past compensation.
- The sale occurred at a price significantly higher than the SAR exercise price ($94.71 vs. $63.40), demonstrating a profitable transaction for the CEO.
Negatives
- The CEO sold a portion of his shares, which could be interpreted as a reduction in direct equity exposure, although it was part of a pre-planned transaction.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Shareholders: May view the CEO's sale of shares as a slight reduction in direct insider alignment, though it was pre-planned and for compensation realization.
Key Dates
| Date | Description |
|---|---|
| 07/01/2022 | Stock Appreciation Rights became exercisable. |
| 06/30/2025 | Rule 10b5-1 plan adopted by Doron Blachar. |
| 09/29/2025 | Date of SAR exercise and common stock sale transactions. |
| 09/30/2025 | Date Form 4 was signed. |
| 07/01/2026 | Expiration date of the Stock Appreciation Rights. |
Recommendation
holdThis Form 4 reports a routine insider transaction where the CEO exercised Stock Appreciation Rights and subsequently sold a portion of the resulting shares under a pre-established 10b5-1 plan. Such transactions are typically for personal financial planning and do not inherently signal a change in the company's fundamental outlook or warrant a change in investment recommendation. The sale was pre-planned, reducing its interpretative significance regarding future company performance. Therefore, a 'hold' recommendation is appropriate as this filing does not provide new information to alter an existing investment thesis.
Keywords
Ormat Technologies, ORA, Doron Blachar, SEC Form 4, Insider Trading, Stock Appreciation Rights, SARs, 10b5-1 Plan, CEO Stock Sale
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.